Topic

Pennsylvania

A collection of 524 issues

How to Get Fintepla (fenfluramine) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Prior Authorization Guide

Answer Box: Getting Fintepla Covered by Blue Cross Blue Shield in Pennsylvania Blue Cross Blue Shield plans in Pennsylvania require prior authorization for Fintepla (fenfluramine) with specific REMS program enrollment and cardiac monitoring documentation. The fastest path to approval involves: (1) completing REMS enrollment with baseline echocardiogram, (2) documenting diagnosis

How to Get Aldurazyme (laronidase) Covered by Blue Cross Blue Shield in Pennsylvania: Prior Authorization, Appeals, and Cost Assistance

Answer Box: Getting Aldurazyme Covered by Blue Cross Blue Shield in Pennsylvania Aldurazyme (laronidase) is covered by Blue Cross Blue Shield plans in Pennsylvania but requires prior authorization and is placed on specialty tier (Tier 5). To get approved: (1) Your doctor must submit a prior authorization request with MPS

How to Get Daybue (Trofinetide) Covered by Aetna CVS Health in Pennsylvania: Complete Requirements Checklist and Appeal Guide

Quick Answer: Getting Daybue Covered in Pennsylvania Aetna CVS Health requires prior authorization for Daybue (trofinetide) in Pennsylvania. You'll need confirmed Rett syndrome diagnosis with MECP2 genetic testing, patient age ≥2 years, and prescription from a neurologist or geneticist. The fastest path: have your specialist submit the prior

How to Get Amondys 45 (Casimersen) Covered by Cigna in Pennsylvania: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Amondys 45 (Casimersen) Covered by Cigna in Pennsylvania Fastest path to approval: Submit prior authorization through Cigna's provider portal or call 1-800-882-4462 with genetic testing confirming exon 45-amenable DMD mutation, specialist prescription, and infusion plan. If denied, file internal appeal within 60 days, then Pennsylvania

If Jynarque (Tolvaptan) Isn't Approved by Blue Cross Blue Shield in Pennsylvania: Formulary Alternatives & Exception Paths

Answer Box: Your Options When Jynarque Is Denied If Blue Cross Blue Shield Pennsylvania denies Jynarque (tolvaptan) for ADPKD, you have three paths: request a step therapy exception with documented rapid progression (Mayo class 1C-1E), try formulary alternatives like supportive therapies while building your case, or file an appeal through

How to Get Photrexa (Riboflavin) Covered by Aetna CVS Health in Pennsylvania: Prior Authorization Guide

Quick Answer: Getting Photrexa Covered by Aetna CVS Health in Pennsylvania Aetna CVS Health requires prior authorization for Photrexa (riboflavin ophthalmic solution) used in FDA-approved corneal cross-linking for progressive keratoconus in Pennsylvania. Your fastest path to approval: (1) Gather documented progression evidence (serial topography showing Kmax increases, pachymetry showing thinning)

How to Get Soliris (Eculizumab) Covered by Humana in Pennsylvania: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Soliris (Eculizumab) Covered by Humana in Pennsylvania Yes, Humana covers Soliris (eculizumab) in Pennsylvania, but requires strict prior authorization. The medication typically falls under Tier 5 (specialty tier) with 25-33% coinsurance. Your fastest path to approval: 1) Ensure meningococcal vaccination is completed at least 2 weeks before

How to Get Dojolvi (Triheptanoin) Covered by UnitedHealthcare in Pennsylvania: Complete PA Guide & Appeal Scripts

Answer Box: Getting Dojolvi Covered by UnitedHealthcare in Pennsylvania Quick Path to Approval: UnitedHealthcare requires prior authorization for Dojolvi (triheptanoin) with molecular confirmation of long-chain fatty acid oxidation disorder (LCFAOD), prescription by a board-certified medical geneticist, and no concurrent MCT oil use. If denied, Pennsylvania's new external review

Myths vs. Facts: Getting Idelvion (Albutrepenonacog Alfa) Covered by Humana in Pennsylvania

Answer Box: Get Idelvion Covered by Humana in Pennsylvania Fastest path to approval: Submit prior authorization through Humana Provider Portal with factor IX deficiency documentation, bleeding history, and inhibitor status. If denied, appeal within 65 days—Pennsylvania's external review program has a 50% overturn rate. Start today: Contact

Myths vs. Facts: Getting Zolgensma Covered by Cigna in Pennsylvania (Complete Appeals Guide)

Answer Box: Getting Zolgensma Covered by Cigna in Pennsylvania Myth: If your doctor prescribes Zolgensma, Cigna automatically covers it. Fact: Prior authorization is mandatory, requiring genetic confirmation, anti-AAV9 antibody testing ≤1:50, and certified site-of-care documentation. In Pennsylvania, if denied, you have strong appeal rights—the state's external